Regenxbio
RGNX
RGNX
168 hedge funds and large institutions have $1.04B invested in Regenxbio in 2019 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 72 increasing their positions, 54 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
10% less funds holding
Funds holding: 186 → 168 (-18)
31% less capital invested
Capital invested by funds: $1.51B → $1.04B (-$470M)
55% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 33
Holders
168
Holding in Top 10
2
Calls
$7.94M
Puts
$6.61M
Top Buyers
| 1 | +$34.6M | |
| 2 | +$8.93M | |
| 3 | +$8.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.36M |
| 5 |
BlackRock
New York
|
+$3.64M |
Top Sellers
| 1 | -$18M | |
| 2 | -$12.9M | |
| 3 | -$9.19M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$7.83M |
| 5 |
Bank of New York Mellon
New York
|
-$5.28M |